37. 膿疱性乾癬（汎発型） Generalised pustular psoriasis Clinical trials / Disease details

臨床試験数 : 74 / 薬物数 : 53 - (DrugBank : 20) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 101

23 trials found

diseases per page:

Showing 1 to 10 of 23 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003080-56-ES (EUCTR)	07/02/2022	14/12/2021	A 5-year study to test BI 655130in patients with GeneralizedPustular Psoriasis who took part in prev ...	An open-label, long term extension study to assess the safety andefficacy of BI 655130treatment in p ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim España S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 2	United States;Philippines;Taiwan;Greece;Thailand;Spain;Ukraine;Russian Federation;Chile;Israel;Colom ...
2	JPRN-jRCT2041210087	01/11/2021	20/10/2021	A 5-year study to test BI 655130in patients with Generalized Pustular Psoriasis who took part in pre ...	An open-label, long term extension study to assess the safety and efficacy of BI 655130treatment in ...	Generalized Pustular Psoriasis (GPP)	Drug: BI 655130(Spesolimab) / Solution for infusion Drug: BI 655130(Spesolimab) / Solution for inject ...	Yamada Nobuko	NULL	Recruiting	>= 12age old	<= 75age old	Both	4	Phase 2	Argentina;Australia;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czech Republic;Egypt;France;Georgi ...
3	EUCTR2018-003080-56-BG (EUCTR)	08/09/2021	30/07/2021	A 5-year study to test BI 655130in patients with GeneralizedPustular Psoriasis who took part in prev ...	An open-label, long term extension study to assess the safety andefficacy of BI 655130treatment in p ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim RCV GmbH & Co KG	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 2	United States;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Israel;Chile;Russian Federation;Colom ...
4	EUCTR2018-003081-14-HR (EUCTR)	26/08/2021	03/12/2021	A study to test whether BI 655130(Spesolimab) prevents flare-ups in patients with Generalized Pustul ...	Effisayil™ 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim RCV GmbH & Co KG	NULL	Not Recruiting			Female: yes Male: yes	98	Phase 2	United States;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Russian Federation;Chile;Israel;Colom ...
5	EUCTR2018-003081-14-BG (EUCTR)	17/05/2021	14/04/2021	A study to test whether BI 655130(Spesolimab) prevents flare-ups in patients with Generalized Pustul ...	Effisayil™ 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim RCV GmbH & Co KG	NULL	Not Recruiting			Female: yes Male: yes	98	Phase 2	United States;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Israel;Chile;Russian Federation;Colom ...
6	EUCTR2018-003081-14-PL (EUCTR)	24/09/2020	01/06/2020	A study to test whether BI 655130(Spesolimab) prevents flare-ups in patients with Generalized Pustul ...	Effisayil™ 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim RCV GmbH & Co KG	NULL	Not Recruiting			Female: yes Male: yes	98	Phase 2	United States;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Israel;Chile;Russian Federation;Colom ...
7	JPRN-JapicCTI-205387	03/8/2020	23/07/2020	A study to test whether BI 655130(Spesolimab) prevents flare-ups in patients with Generalized Pustul ...	Effisayil(TM) 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase I ...	Generalized Pustular Psoriasis (GPP)	Intervention name : spesolimab INN of the intervention : spesolimab Dosage And administration of the i ...	Boehringer Ingelheim	NULL	complete	12	75	BOTH	120	Phase 2	Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa
8	NCT04399837 (ClinicalTrials.gov)	June 4, 2020	20/5/2020	A Study to Test Whether BI 655130(Spesolimab) Prevents Flare-ups in Patients With Generalized Pustul ...	Effisayil™ 2: Multi-center, Randomized, Parallel Group, Double Blind, Placebo Controlled, Phase IIb ...	Generalized Pustular Psoriasis	Drug: Spesolimab;Drug: Placebo	Boehringer Ingelheim	NULL	Active, not recruiting	12 Years	75 Years	All	123	Phase 2	United States;Argentina;Belgium;Bulgaria;Chile;China;Croatia;France;Germany;Greece;Italy;Japan;Korea ...
9	EUCTR2018-003081-14-DE (EUCTR)	16/04/2020	16/12/2019	A study to test whether BI 655130(Spesolimab) prevents flare-ups in patients with Generalized Pustul ...	Effisayil™ 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim Pharma GmbH & Co. KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	98	Phase 2	United States;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Israel;Chile;Russian Federation;Colom ...
10	EUCTR2018-003081-14-IT (EUCTR)	16/03/2020	15/06/2021	A study to test whether BI 655130(Spesolimab) prevents flare-ups inpatients with Generalized Pustula ...	Effisayil™ 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb ...	Generalized Pustular Psoriasis MedDRA version: 21.0;Level: LLT;Classification code 10037159;Term: Ps ...	Product Name: Spesolimab Product Code: [BI 655130] INN or Proposed INN: Spesolimab Other descriptive na ...	BOEHRINGER-INGELHEIM ITALIA S.P.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	98	Phase 2	United States;Taiwan;Greece;Spain;Thailand;Russian Federation;Chile;Italy;Vietnam;France;Malaysia;Au ...

First Previous1 2 3Next Last